Head and Neck Cancer
Showing NaN - NaN of 90
Head Neck Cancer, Head and Neck Tumors, Squamous Cell Carcinoma of Head and Neck Trial in Chicago (Xevinapant, Carboplatin,
Not yet recruiting
- Head and Neck Cancer
- +2 more
- Xevinapant
- +3 more
-
Chicago, IllinoisUniversity of Chicago Medicine Comprehensive Cancer Center
Oct 25, 2023
Head Neck Cancer, Dysphagia, Oropharyngeal Dysphagia Trial in Chicago, Evanston (Respiratory-Swallow Phase Training, Swallow
Recruiting
- Head and Neck Cancer
- +3 more
- Respiratory-Swallow Phase Training
- Swallow Practice
-
Chicago, Illinois
- +1 more
Dec 13, 2022
Gastrointestinal Cancer, Breast Cancer, Head Neck Cancer Trial in Chicago (Pharmacogenomics (PGx) Testing and Genomics
Recruiting
- Gastrointestinal Cancer
- +4 more
- Availability of clinical decision support based on pharmacogenomic results.
-
Chicago, IllinoisUniversity of Chicago Medical Center
Oct 20, 2022
Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma Trial in Chicago (HB-201, HB-202, Carboplatin)
Recruiting
- Human Papilloma Virus
- +3 more
- HB-201
- +4 more
-
Chicago, IllinoisUniversity of Chicago
Aug 11, 2022
Endometrial Tumors, Ovarian Cancer, Solid Tumor Trial in United States (COM701 in combination with BMS-986207 and nivolumab.)
Recruiting
- Endometrial Neoplasms
- +3 more
- COM701 in combination with BMS-986207 and nivolumab.
-
Chicago, Illinois
- +8 more
Aug 8, 2022
Radiation-Induced Xerostomia, Head Neck Cancer, Radiation Toxicity Trial in United States (Standard Oral Hygiene, Standard Oral
Completed
- Radiation-Induced Xerostomia
- +3 more
- Standard Oral Hygiene
- +2 more
-
Burbank, California
- +35 more
Jul 29, 2022
Head and Neck Squamous Cell Carcinoma, Head Neck Cancer, Head Cancer Trial in United States (IK-175 + nivolumab)
Not yet recruiting
- Head and Neck Squamous Cell Carcinoma
- +5 more
- IK-175 + nivolumab
-
Chicago, Illinois
- +3 more
Jul 26, 2022
Head Neck Cancer, Dysphagia Trial in Chicago, Hines (Respiratory Swallow Training)
Recruiting
- Head and Neck Cancer
- Dysphagia
- Respiratory Swallow Training
-
Chicago, Illinois
- +1 more
Jun 10, 2022
Head Neck Cancer Trial in United States (drug, radiation, procedure)
Head Neck Cancer, Squamous Cell Carcinoma of the Head and Neck Trial in Atlanta, Chicago, Philadelphia (Pembrolizumab, Placebo)
Active, not recruiting
- Head and Neck Cancer
- Squamous Cell Carcinoma of the Head and Neck
- Pembrolizumab
- Placebo
-
Atlanta, Georgia
- +3 more
Apr 13, 2022
Head Neck Cancer Trial in Canada, Saudi Arabia, United States (cisplatin, 3-dimensional conformal radiation therapy,
Active, not recruiting
- Head and Neck Cancer
- cisplatin
- +2 more
-
Birmingham, Alabama
- +267 more
Apr 6, 2022
Head Neck Cancer, Carcinoma, Squamous Cell, Tumors, Oral Trial in Chicago, Dallas (Intensity Modulated Radiation Therapy, chemo)
Completed
- Head and Neck Cancer
- +3 more
- Intensity Modulated Radiation Therapy
- chemotherapy
-
Chicago, Illinois
- +1 more
Feb 16, 2022
Advanced Solid Tumors, Head Neck Cancer, Pancreatic Cancer Trial in United States (Cabiralizumab, Nivolumab)
Completed
- Advanced Solid Tumors
- +6 more
- Cabiralizumab
- Nivolumab
-
Scottsdale, Arizona
- +38 more
Jan 5, 2022
Prostate Cancer, Melanoma, Renal Cell Carcinoma Trial in United States (MGA271)
Completed
- Prostate Cancer
- +6 more
- MGA271
-
Los Angeles, California
- +11 more
Feb 4, 2022
Solid Tumors, Head Neck Cancer, Lung Cancer Trial in United States (MEDI4736, INCB024360)
Completed
- Solid Tumors
- +3 more
-
San Francisco, California
- +12 more
Jan 7, 2022
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab)
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
-
Irvine, California
- +10 more
Nov 4, 2021
Head Neck Cancer, Head and Neck Squamous Cell Carcinoma Trial in Worldwide (Evorpacept, Pembrolizumab, Cisplatin/Carboplatin;
Recruiting
- Head and Neck Cancer
- Head and Neck Squamous Cell Carcinoma
- Evorpacept
- +2 more
-
Irvine, California
- +10 more
Nov 4, 2021
Head Neck Cancer Trial in United States (fruit and vegetable extracts, )
Completed
- Head and Neck Cancer
- fruit and vegetable extracts
- placebo
-
Santa Rosa, California
- +27 more
Sep 7, 2021
Head Neck Cancer Trial in Worldwide (cetuximab, intensity-modulated radiation therapy)
Active, not recruiting
- Head and Neck Cancer
- cetuximab
- intensity-modulated radiation therapy
-
Birmingham, Alabama
- +263 more
Aug 2, 2021
Head Neck Cancer Trial in Chicago (Educational website)
Terminated
- Head and Neck Cancer
- Educational website
-
Chicago, IllinoisUniversity of Illinois at Chicago
Apr 6, 2021
Head Neck Cancer Trial in Chicago (Isocaloric and iso-nitrogenous standard enteral tube feeds, Nestle IMPACT AR)
Withdrawn
- Head and Neck Cancer
- Isocaloric and iso-nitrogenous standard enteral tube feeds
- Nestle IMPACT AR
-
Chicago, IllinoisUniversity of Illinois at Chicago
Apr 6, 2021